Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bone Biologics Corporatio...

    NASDAQ: BBLG · Real-Time Price · USD
    2.20
    0.12 (5.77%)
    At close: Aug 19, 2025, 11:56 AM
    5.77%
    Bid 2.12
    Market Cap 3.53M
    Revenue (ttm) n/a
    Net Income (ttm) -4.26M
    EPS (ttm) -21.39
    PE Ratio (ttm) -0.1
    Forward PE -1.34
    Analyst n/a
    Ask 2.15
    Volume 33,081
    Avg. Volume (20D) 523,793
    Open 2.13
    Previous Close 2.08
    Day's Range 2.12 - 2.20
    52-Week Range 2.08 - 16.50
    Beta 2.72

    About BBLG

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol BBLG
    Website n/a
    Full Company Profile
    1 month ago
    +10.1%
    Bone Biologics shares are trading higher after the... Unlock content with Pro Subscription
    1 month ago
    -24.5%
    Bone Biologics shares are trading lower after the company announced a mixed shelf offering of up to $35 million.
    news image

    1 month ago · businesswire.com

    Bone Biologics Announces Closing of $5.0 Million Public Offering

    BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announce...

    news image

    1 month ago · benzinga.com

    Why Is Bone Biologics Stock Surging On Friday?

    Bone Biologics Corporation BBLG stock is trading higher on Friday, with a session volume of 17.22 million compared to the average volume of 38.795K as per data from Benzinga Pro.

    news image

    1 month ago · businesswire.com

    Bone Biologics Announces Pricing of $5.0 Million Public Offering

    BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announce...

    news image

    1 month ago · businesswire.com

    Bone Biologics Files Patent Application for Bone Regeneration Technology

    BURLINGTON, Mass.--(BUSINESS WIRE)---- $BBLG #Bonebiologics--Bone Biologics files U.S. patent application for bone regeneration technology.

    news image

    1 month ago · businesswire.com

    Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

    BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announce...

    news image

    2 months ago · businesswire.com

    Bone Biologics Announces 1-for-6 Reverse Stock Split

    BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announce...

    Add to Watchlist